Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Minoxidil, when applied to the scalp, can stimulate hair growth but effects vary, stop if treatment ends, and it may cause side effects like fluid retention.

The document concludes that protecting skin from the sun, avoiding smoking, and using treatments like Minoxidil and Finasteride can help manage skin and hair aging.

Granuloma faciale can occur on the scalp, especially in people with advanced hair loss, and may improve with treatment.

Effective epilepsy management involves accurate diagnosis, understanding seizure types, identifying causes, and choosing the right treatment.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

A substance from a specific gel helped to grow hair effectively in mice, suggesting it could potentially be used to treat hair loss in humans.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Various treatments can improve post-acne scars, but results vary.

PRP treatment helps hair growth and rebalances scalp bacteria in androgenetic alopecia patients.

Combining ciprofloxacin with other treatments may improve its effectiveness against resistant bacteria.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

The hydrogel treatment speeds up healing of chronic wounds.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.